Collectively, IMD-4482 reduced cellular proliferation through an inability to progress from the G0/G1 phase of the cell cycle, which leads to apoptosis in PAI-1-positive ovarian cancer cells. Here, SERPINE1 is linked to ovarian carcinoma.